You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Amgen
since
auto-detected in 12 stories
43 days ago
Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology.
4 months ago
Stocks making the biggest moves after hours: Chipotle, Advanced Micro Devices, Amgen and more ⊕
These are the stocks posting the largest moves in extended trading.
Amgen CEO says weight loss drug can address 'patient persistence issue' ⊖
Amgen CEO Bob Bradway discussed his company's weight loss drug in an interview with CNBC's Jim Cramer.
5 months ago
Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more ○
Check out some of the biggest movers in midday trading.
This biotech name is evolving into a major obesity play. How to trade it with options ⊕⊕
Key catalysts, including growing confidence around Amgen’s MariTide obesity program, could transform the name into a growth story.
6 months ago
CEO of drugmaker Amgen talks new results from cholesterol drug trial ⊖
Amgen CEO Bob Bradway told CNBC's Jim Cramer about his company's treatment to reduce heart attack risk.
8 months ago
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers ⊕
Amgen is the latest drugmaker to sell certain drugs directly to consumers amid pressure from President Donald Trump. Meanwhile, Dr. Oz talks GLP-1s for obesity.
9 months ago
Amgen to invest $600 million in new research and development facility in California ○
It is the latest U.S. investment by a drugmaker as President Donald Trump threatens to impose tariffs on pharmaceuticals imported into the U.S.
11 months ago
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan ○
found
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.
13 months ago
Trump pharma tariffs would raise U.S. drug costs by $51 billion annually, report finds ○
found
Pharmaceutical Research and Manufacturers of America includes Amgen, Bristol Myers Squibb, Eli Lilly, and Pfizer, among others.